Fludrocortisone acetate tablets: director disqualification
The CMA has secured the disqualification of a director whose company admitted it breached competition law.
Director disqualification undertakings
1 June 2020: The Competition and Markets Authority (CMA) secured a legally binding disqualification undertaking from Mr Amit Patel, director of Amilco Limited. Mr Patel has given a disqualification undertaking not to act as a director of any UK company for 5 years as of 13 July 2020.
Under the Company Directors Disqualification Act, the CMA has the power to apply to the court to disqualify a director from holding company directorships or performing certain roles in relation to a company for a specified period, if a company which he or she is a director of has breached competition law. The Act also allows the CMA to accept a disqualification undertaking from a director instead of bringing proceedings, which has the same legal effect as a disqualification order.
- (4.6.20)
- Press release: Pharma company director disqualified for competition law breaches (4.6.20)
Further details about the CMA’s investigation can be found on the anti-competitive agreements and conduct in the pharmaceutical sector case page.
Contacts
Director of Litigation
Jessica Radke (jessica.radke@cma.gov.uk)
CMA press office
press@cma.gov.uk or call 020 3738 6460